Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by 24 Hour Recall

Research Leaders

6 sponsors active, led by National Urea Cycle Disorder Foundation

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • 24 Hour Recall1
  • Mdr Diet Assessment1

Active Sponsors

  • National Urea Cycle Disorder Foundation1
  • Emma Marie Caroline Slack1
  • Oregon Health and Science University1
  • University Children's Hospital1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top Investigators

Related Conditions

  • Urea Cycle Disorder2
  • Maple Syrup Urine Disease1
  • Methylmalonic Acidemia1
  • Methylmalonic Aciduria1
  • Inborn Errors Of Metabolism1

Activity Timeline